X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4680) 4680
Book Review (1170) 1170
Publication (471) 471
Newsletter (67) 67
Conference Proceeding (19) 19
Book Chapter (18) 18
Magazine Article (14) 14
Newspaper Article (7) 7
Dissertation (6) 6
Book / eBook (2) 2
Reference (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3880) 3880
humans (3829) 3829
thalidomide - analogs & derivatives (2888) 2888
thalidomide (1998) 1998
thalidomide - therapeutic use (1931) 1931
male (1759) 1759
female (1614) 1614
oncology (1484) 1484
multiple myeloma - drug therapy (1343) 1343
middle aged (1341) 1341
hematology (1339) 1339
aged (1290) 1290
thalidomide - administration & dosage (1240) 1240
lenalidomide (1216) 1216
multiple myeloma (1067) 1067
treatment outcome (965) 965
thalidomide - adverse effects (925) 925
antineoplastic combined chemotherapy protocols - therapeutic use (912) 912
adult (897) 897
bortezomib (815) 815
antineoplastic agents - therapeutic use (762) 762
thalidomide - pharmacology (761) 761
animals (747) 747
therapy (633) 633
aged, 80 and over (567) 567
cancer (540) 540
care and treatment (507) 507
dexamethasone - administration & dosage (491) 491
pharmacology & pharmacy (486) 486
dexamethasone (457) 457
chemotherapy (452) 452
multiple-myeloma (436) 436
stem-cell transplantation (427) 427
drug therapy (388) 388
angiogenesis inhibitors - therapeutic use (380) 380
abridged index medicus (371) 371
survival (371) 371
multiple myeloma - pathology (367) 367
immunologic factors - therapeutic use (362) 362
antineoplastic combined chemotherapy protocols - adverse effects (354) 354
research (352) 352
mice (349) 349
medicine & public health (342) 342
angiogenesis (325) 325
recurrence (323) 323
disease-free survival (299) 299
hematology, oncology and palliative medicine (295) 295
analysis (293) 293
prognosis (293) 293
clinical trials as topic (292) 292
multiple myeloma - therapy (287) 287
antineoplastic agents - adverse effects (285) 285
myelodysplastic syndromes - drug therapy (283) 283
multiple myeloma - mortality (271) 271
plus dexamethasone (267) 267
angiogenesis inhibitors (266) 266
dose-response relationship, drug (262) 262
antineoplastic agents - pharmacology (257) 257
transplantation (257) 257
boronic acids - therapeutic use (247) 247
pyrazines - therapeutic use (247) 247
health aspects (245) 245
necrosis-factor-alpha (231) 231
drug therapy, combination (225) 225
immunosuppressive agents - therapeutic use (224) 224
article (223) 223
antineoplastic combined chemotherapy protocols - administration & dosage (222) 222
efficacy (219) 219
expression (219) 219
myelodysplastic syndromes (219) 219
analogs (218) 218
clinical trials (217) 217
disease progression (215) 215
remission induction (215) 215
tnf-alpha (215) 215
combination (214) 214
dexamethasone - therapeutic use (213) 213
antineoplastic agents - administration & dosage (210) 210
cell line, tumor (208) 208
cells (208) 208
trial (206) 206
retrospective studies (205) 205
immunology (204) 204
boronic acids - administration & dosage (203) 203
pyrazines - administration & dosage (202) 202
pomalidomide (198) 198
drug administration schedule (195) 195
thalidomide analogs (194) 194
survival analysis (193) 193
risk factors (192) 192
apoptosis (191) 191
myelodysplastic syndromes - genetics (191) 191
survival rate (191) 191
dermatology (185) 185
multiple myeloma - diagnosis (182) 182
myeloma (181) 181
follow-up studies (179) 179
medicine, general & internal (179) 179
in-vitro (178) 178
dosage and administration (176) 176
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4540) 4540
Japanese (100) 100
French (37) 37
German (36) 36
Chinese (27) 27
Spanish (19) 19
Czech (18) 18
Polish (5) 5
Danish (2) 2
Hungarian (2) 2
Portuguese (2) 2
Italian (1) 1
Korean (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Structural and Molecular Biology, ISSN 1545-9993, 08/2014, Volume 21, Issue 9, pp. 803 - 809
Journal Article
Science, ISSN 0036-8075, 11/2018, Volume 362, Issue 6414, pp. 558 - 558
Journal Article
Tetrahedron, ISSN 0040-4020, 10/2016, Volume 72, Issue 40, pp. 6136 - 6141
Click analogues of thalidomide were prepared from 3-azidoglutarimide and a diverse array of arylacetylenes and -ethynyl/ -propargyl phthalimide derivatives.... 
Teratogenesis | Angiogenesis | TNF-α | EM-12 | Multiple myeloma | Thalidomide | Cancer | MULTIPLE-MYELOMA | ACTIVATION | TNF-alpha | ENANTIOMERS | CHEMISTRY, ORGANIC | PHTHALIMIDINE | CYCLOADDITION | ANTIANGIOGENIC ACTIVITY | METABOLISM | CHEMISTRY | DERIVATIVES | Triazoles | Synthesis | Sodium | Phthalimides | Reagents | Coupling | Derivatives | Arrays
Journal Article
Journal of Immunology, ISSN 0022-1767, 07/1999, Volume 163, Issue 1, pp. 380 - 386
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 10/2002, Volume 130, Issue 1, pp. 75 - 84
Thalidomide (Thd) is clinically useful in a number of conditions where its efficacy is probably related to its anti‐TNF ‐α activity. More recently, Thd has... 
immunomodulation | T lymphocyte | co‐stimulation | thalidomide | TNF | Co-stimulation | Immunomodulation | Thalidomide | MULTIPLE-MYELOMA | ACTIVATION | PHASE-II | IMMUNOLOGY | co-stimulation | POTENT INHIBITORS | CC-3052 | INHIBITORY ACTIVITY | IN-VITRO | THERAPY | IMMUNODEFICIENCY-VIRUS INFECTION | APHTHOUS ULCERS | Adjuvants, Immunologic - pharmacology | Antigens, CD - biosynthesis | Humans | Middle Aged | Tumor Necrosis Factor-alpha - genetics | Male | Thalidomide - pharmacology | Antigens, CD - genetics | Receptors, Interleukin-2 - genetics | Thalidomide - analogs & derivatives | Neoplasms - therapy | Neoplasms - blood | Receptors, Tumor Necrosis Factor - antagonists & inhibitors | Receptors, Tumor Necrosis Factor, Type II | CD8-Positive T-Lymphocytes - metabolism | Adult | Female | Adjuvants, Immunologic - therapeutic use | Receptors, Tumor Necrosis Factor - genetics | Cells, Cultured - drug effects | Enzyme-Linked Immunosorbent Assay | Lenalidomide | Receptors, Interleukin-2 - biosynthesis | Antibodies, Monoclonal - pharmacology | CD4-Positive T-Lymphocytes - metabolism | Solubility | Phosphodiesterase Inhibitors - pharmacology | Inflammation | Antigens, CD - drug effects | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | CD8-Positive T-Lymphocytes - drug effects | CD3 Complex - immunology | Lipopolysaccharides - pharmacology | Receptors, Tumor Necrosis Factor - biosynthesis | Aged | Cells, Cultured - metabolism | Thalidomide - therapeutic use | Tumor Necrosis Factor-alpha - biosynthesis | CD4-Positive T-Lymphocytes - drug effects | Receptors, Tumor Necrosis Factor - drug effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus | Basic Immunology
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2016, Volume 22, Issue 7, pp. 706 - 707
Two recent studies provide novel insights into the mechanism of action of thalidomide analogs in multiple myeloma and del(5q) myelodysplastic syndrome. They... 
TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | DEGRADATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL BIOLOGY | Thalidomide - analogs & derivatives | Humans | Molecular chaperones | Patient outcomes | Genetic aspects | Drug therapy | Thalidomide | Health aspects | Myelodysplastic syndromes | Studies | Calcium | Cancer | Tumors | Index Medicus
Journal Article
Journal Article
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 04/2018, Volume 28, Issue 7, pp. 1223 - 1227
Journal Article